These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1149 related articles for article (PubMed ID: 11266517)

  • 1. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study.
    Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC
    Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
    Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A
    Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations.
    Scarpa A; Capelli P; Zamboni G; Oda T; Mukai K; Bonetti F; Martignoni G; Iacono C; Serio G; Hirohashi S
    Am J Pathol; 1993 Apr; 142(4):1163-72. PubMed ID: 8475992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
    Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
    Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.
    Zhang L; Sanderson SO; Lloyd RV; Smyrk TC
    Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
    Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
    Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
    Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
    Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoma and tiny carcinoma in adenoma of the papilla of Vater--p53 and PCNA.
    Sato T; Konishi K; Kimura H; Maeda K; Yabushita K; Tsuji M; Miwa A
    Hepatogastroenterology; 1999; 46(27):1959-62. PubMed ID: 10430377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions.
    Takashima M; Ueki T; Nagai E; Yao T; Yamaguchi K; Tanaka M; Tsuneyoshi M
    Mod Pathol; 2000 Dec; 13(12):1300-7. PubMed ID: 11144926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
    Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
    Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K-ras mutation in adenomas and carcinomas of the ampulla of vater.
    Howe JR; Klimstra DS; Cordon-Cardo C; Paty PB; Park PY; Brennan MF
    Clin Cancer Res; 1997 Jan; 3(1):129-33. PubMed ID: 9815548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine cells in ampullary carcinoma.
    Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A; Funata N
    J Hepatobiliary Pancreat Surg; 2009; 16(3):322-7. PubMed ID: 19214369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging.
    Maitra A; Ashfaq R; Gunn CR; Rahman A; Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Wilentz RE
    Am J Clin Pathol; 2002 Aug; 118(2):194-201. PubMed ID: 12162677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.
    DiGiuseppe JA; Hruban RH; Offerhaus GJ; Clement MJ; van den Berg FM; Cameron JL; van Mansfeld AD
    Am J Pathol; 1994 May; 144(5):889-95. PubMed ID: 8178941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis.
    Löhr M; Klöppel G; Maisonneuve P; Lowenfels AB; Lüttges J
    Neoplasia; 2005 Jan; 7(1):17-23. PubMed ID: 15720814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.
    Biankin AV; Kench JG; Morey AL; Lee CS; Biankin SA; Head DR; Hugh TB; Henshall SM; Sutherland RL
    Cancer Res; 2001 Dec; 61(24):8830-7. PubMed ID: 11751405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
    Tomaszewska R
    Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic intraepithelial neoplasia and infiltrating adenocarcinoma: analysis of progression and recurrence by DPC4 immunohistochemical labeling.
    McCarthy DM; Brat DJ; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Hum Pathol; 2001 Jun; 32(6):638-42. PubMed ID: 11431719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.
    Wilentz RE; Iacobuzio-Donahue CA; Argani P; McCarthy DM; Parsons JL; Yeo CJ; Kern SE; Hruban RH
    Cancer Res; 2000 Apr; 60(7):2002-6. PubMed ID: 10766191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients.
    Santini D; Vincenzi B; Tonini G; Scarpa S; Vasaturo F; Malacrino C; Vecchio F; Borzomati D; Valeri S; Coppola R; Magistrelli P; Nuzzo G; Picciocchi A
    Clin Cancer Res; 2005 May; 11(10):3784-9. PubMed ID: 15897577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.